163 related articles for article (PubMed ID: 36048146)
21. Irreversible electroporation combined with chemotherapy and PD-1/PD-L1 blockade enhanced antitumor immunity for locally advanced pancreatic cancer.
Ma Y; Xing Y; Li H; Yuan T; Liang B; Li R; Li J; Li Z; Li S; Niu L
Front Immunol; 2023; 14():1193040. PubMed ID: 37691923
[TBL] [Abstract][Full Text] [Related]
22. Percutaneous irreversible electroporation combined with allogeneic natural killer cell immunotherapy for patients with unresectable (stage III/IV) pancreatic cancer: a promising treatment.
Lin M; Liang S; Wang X; Liang Y; Zhang M; Chen J; Niu L; Xu K
J Cancer Res Clin Oncol; 2017 Dec; 143(12):2607-2618. PubMed ID: 28871458
[TBL] [Abstract][Full Text] [Related]
23. Open irreversible electroporation for isolated local recurrence of pancreatic ductal adenocarcinoma after primary surgery.
Heger U; Mack C; Tjaden C; Pan F; Pausch T; Hinz U; Sommer CM; Hackert T
Pancreatology; 2021 Oct; 21(7):1349-1355. PubMed ID: 34404600
[TBL] [Abstract][Full Text] [Related]
24. The use of IRE in multi-modality treatment for oligometastatic pancreatic cancer.
Hong Y; Rice J; Sharma D; Martin RCG
Am J Surg; 2018 Jul; 216(1):106-110. PubMed ID: 29506753
[TBL] [Abstract][Full Text] [Related]
25. Irreversible electroporation and adjuvant chemoradiotherapy for locally advanced pancreatic carcinoma.
Xu K; Chen Y; Su J; Su M; Yan L
J Cancer Res Ther; 2020; 16(2):280-285. PubMed ID: 32474514
[TBL] [Abstract][Full Text] [Related]
26. Value of CT-Guided Percutaneous Irreversible Electroporation Added to FOLFIRINOX Chemotherapy in Locally Advanced Pancreatic Cancer: A Post Hoc Comparison.
van Veldhuisen E; Vroomen LG; Ruarus AH; Derksen TC; Busch OR; de Jong MC; Kazemier G; Puijk RS; Sorgedrager NS; Vogel JA; Scheffer HJ; van Lienden KP; Wilmink JW; Besselink MG; Meijerink MR
J Vasc Interv Radiol; 2020 Oct; 31(10):1600-1608. PubMed ID: 32861569
[TBL] [Abstract][Full Text] [Related]
27. [Combining intraoperative ultrasound-guided irreversible electroporation with chemotherapy for treating locally advanced pancreatic cancer: a clinical report of 64 cases].
Li SP; He CB; Wang J; Mao YZ; Lao XM; Cui BK; Lin XJ
Zhonghua Wai Ke Za Zhi; 2020 Oct; 58(10):787-792. PubMed ID: 32993267
[No Abstract] [Full Text] [Related]
28. Treatment of locally advanced pancreatic cancer by percutaneous and intraoperative irreversible electroporation: general hospital cancer center experience.
Lambert L; Horejs J; Krska Z; Hoskovec D; Petruzelka L; Krechler T; Kriz P; Briza J
Neoplasma; 2016; 63(2):269-73. PubMed ID: 26774149
[TBL] [Abstract][Full Text] [Related]
29. Single-Institution Experience with Irreversible Electroporation for T4 Pancreatic Cancer: First 50 Patients.
Kluger MD; Epelboym I; Schrope BA; Mahendraraj K; Hecht EM; Susman J; Weintraub JL; Chabot JA
Ann Surg Oncol; 2016 May; 23(5):1736-43. PubMed ID: 26714959
[TBL] [Abstract][Full Text] [Related]
30. Treatment of locally advanced pancreatic cancer with irreversible electroporation - a Danish single center study of safety and feasibility.
Flak RV; Stender MT; Jensen TM; Andersen KL; Henriksen SD; Mortensen PB; Sall M; Thorlacius-Ussing O
Scand J Gastroenterol; 2019 Feb; 54(2):252-258. PubMed ID: 30907286
[TBL] [Abstract][Full Text] [Related]
31. [Comparison of the efficacy of irreversible electroporation and conversional resection for locally advanced pancreatic cancer].
He CB; Wang J; Mao YZ; Lao XM; Li SP
Zhonghua Wai Ke Za Zhi; 2022 Oct; 60(10):948-954. PubMed ID: 36207984
[No Abstract] [Full Text] [Related]
32. Irreversible electroporation of locally advanced pancreatic cancer.
Kwon W; Thomas A; Kluger MD
Semin Oncol; 2021 Feb; 48(1):84-94. PubMed ID: 33648735
[TBL] [Abstract][Full Text] [Related]
33. Percutaneous irreversible electroporation for downstaging and control of unresectable pancreatic adenocarcinoma.
Narayanan G; Hosein PJ; Arora G; Barbery KJ; Froud T; Livingstone AS; Franceschi D; Rocha Lima CM; Yrizarry J
J Vasc Interv Radiol; 2012 Dec; 23(12):1613-21. PubMed ID: 23177107
[TBL] [Abstract][Full Text] [Related]
34. A prospective, multi-institution assessment of irreversible electroporation for treatment of locally advanced pancreatic adenocarcinoma: initial outcomes from the AHPBA pancreatic registry.
Holland MM; Bhutiani N; Kruse EJ; Weiss MJ; Christein JD; White RR; Huang KW; Martin RCG
HPB (Oxford); 2019 Aug; 21(8):1024-1031. PubMed ID: 30737097
[TBL] [Abstract][Full Text] [Related]
35. Ultrasound-guided Percutaneous Irreversible Electroporation for Treatment of Locally Recurrent Pancreatic Cancer After Surgical Resection.
Månsson C; Nilsson A; Nygren P; Karlson BM
Anticancer Res; 2020 May; 40(5):2771-2775. PubMed ID: 32366423
[TBL] [Abstract][Full Text] [Related]
36. The role of irreversible electroporation (IRE) for locally advanced pancreatic cancer: a systematic review of safety and efficacy.
Ansari D; Kristoffersson S; Andersson R; Bergenfeldt M
Scand J Gastroenterol; 2017 Nov; 52(11):1165-1171. PubMed ID: 28687047
[TBL] [Abstract][Full Text] [Related]
37. Percutaneous irreversible electroporation for treatment of locally advanced pancreatic cancer following chemotherapy or radiochemotherapy.
Månsson C; Brahmstaedt R; Nilsson A; Nygren P; Karlson BM
Eur J Surg Oncol; 2016 Sep; 42(9):1401-6. PubMed ID: 26906114
[TBL] [Abstract][Full Text] [Related]
38. Survival Comparison of Neoadjuvant Chemotherapy Followed by Irreversible Electroporation Versus Conversional Resection for Locally Advanced Pancreatic Cancer.
He C; Sun S; Huang X; Zhang Y; Lin X; Li S
Front Oncol; 2020; 10():622318. PubMed ID: 33604301
[TBL] [Abstract][Full Text] [Related]
39. Systematic Review of Irreversible Electroporation Role in Management of Locally Advanced Pancreatic Cancer.
Lafranceschina S; Brunetti O; Delvecchio A; Conticchio M; Ammendola M; Currò G; Piardi T; de'Angelis N; Silvestris N; Memeo R
Cancers (Basel); 2019 Nov; 11(11):. PubMed ID: 31684186
[TBL] [Abstract][Full Text] [Related]
40. Initial experience of irreversible electroporation for locally advanced pancreatic cancer in a Korean population.
Kwon JH; Chung MJ; Park JY; Lee HS; Hwang HK; Kang CM; Lee WJ; Park MS; Kim N; Bang S; Kim MD
Acta Radiol; 2021 Feb; 62(2):164-171. PubMed ID: 32295390
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
